Literature DB >> 14523530

[Prognostic significance of immunohistochemical studies].

M Montenarh1.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14523530     DOI: 10.1007/s00106-003-0957-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


× No keyword cloud information.
  6 in total

Review 1.  Retinoblastoma protein partners.

Authors:  E J Morris; N J Dyson
Journal:  Adv Cancer Res       Date:  2001       Impact factor: 6.242

2.  p53 antibodies: call for quality.

Authors:  A Nickels; M Bureik; M Montenarh; M Pfreundschuh; B Koch
Journal:  Int J Cancer       Date:  1997-11-14       Impact factor: 7.396

3.  Detection of p53 in inflammatory tissue and lymphocytes using immunohistology and flow cytometry: a critical comment.

Authors:  A Nickels; H Selter; M Pfreundschuh; M Montenarh; B Koch
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

Review 4.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

5.  p53 regulates a G2 checkpoint through cyclin B1.

Authors:  S A Innocente; J L Abrahamson; J P Cogswell; J M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB.

Authors:  G A Otterson; R A Kratzke; A Coxon; Y W Kim; F J Kaye
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.